Evading P-glycoprotein mediated-efflux chemoresistance using Solid Lipid Nanoparticles

Marco Cavaco(University of Lisbon), Mafalda Videira(University of Lisbon), Bruna Kreutzer(University of Lisbon), Beatriz Silva Lima(University of Lisbon), María Alexandra Brito(Universidade Federal de Juiz de Fora), Carolina Pereira(University of Lisbon), Luís F. Gouveia(University of Lisbon)
European Journal of Pharmaceutics and Biopharmaceutics
November 1, 2016
10.1016/j.ejpb.2016.10.024
Cited by 59

Related Papers

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
|Nature Biotechnology|2010|406
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases
|Advanced Drug Delivery Reviews|2013|237
Immune system targeting by biodegradable nanoparticles for cancer vaccines
|Journal of Controlled Release|2013|229
Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles
|Journal of drug targeting|2002|210
In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model
|Journal of Controlled Release|2014|140